Sygnus Biotech Logo
SAPSNAS-P
Rx Only
Ready for 24-48h Central Dispatch
In Stock

SAPSNAS-DS 60ML Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download
SyrupPrescription Required (Schedule Drug)

SAPSNAS-P

4.0(1 review)
Verified Quality Batch
Active Drug Composition

Mefenamic Acid 50mg + Paracetamol 125mg

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

SAPSNAS-DS 60ML (Mefenamic Acid 50mg + Paracetamol 250mg) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.

Dosage FormOral Suspension
Packaging Presentation60ml
B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Indicated for therapeutic management within specified clinical indications under qualified physician guidance.

Mechanism of Action (MOA)

The active pharmacological principles in SAPSNAS-DS 60ML deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.

Dosage & Posology

As directed by the registered medical practitioner. Strictly adhere to full course duration.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store below 25°C. Do not freeze. Keep container tightly closed.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentSyrup
Dosage FormOral Suspension
Packaging Type60ml
Regulatory ScheduleSchedule H
Country of OriginIndia
Quality StandardWHO-GMP & ISO 9001:2015
Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

SAPSNAS-P features Mefenamic Acid 50mg + Paracetamol 125mg prepared to high pharmaceutical purity standards.

Therapeutic ClassificationSyrup
Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Verified Practitioner & Distributor Feedback

Customer & Clinical Reviews

Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.

4.0

Based on 1 verified review

5
0 (0%)
4
1 (100%)
3
0 (0%)
2
0 (0%)
1
0 (0%)
Verified Feedback
29 Jun 2026

Supplied across our regional networ for SAPSNAS-P 60ML

SAPSNAS-P 60ML has been supplied across our regional network of licensed retail pharmacies, showing steady clinical recovery across diverse patient age groups in routine care. Clean blister seals and break-resistant packaging prevent any in-transit leakage or product dusting. Provides an ideal balance of therapeutic efficacy, affordable pricing, and supply reliability.

Rakesh Patel•PCD Monopoly Franchise Partner, Ahmedabad
Distributor Inquiries

Questions Regarding SAPSNAS-P

What is the therapeutic indication and composition of SAPSNAS-DS 60ML?

SAPSNAS-DS 60ML contains Mefenamic Acid 50mg + Paracetamol 250mg indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.

What packaging presentations are available for SAPSNAS-DS 60ML?

SAPSNAS-DS 60ML is supplied in tamper-evident 100ml / 200ml PET Bottle with Graduated Measuring Cap, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for SAPSNAS-DS 60ML?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SAPSNAS-DS 60ML along with promotional visual aids, product cards, and marketing support.

What is the regulatory schedule and minimum order quantity (MOQ)?

SAPSNAS-DS 60ML is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.

Related Formulations in Syrup

View all Syrup →
Syrup
S-KRAL

S-KRAL

Oxetacaine 20mg + Sucralfate 1gm

Pack:100ml
Syrup
SB CAIN GEL

SB CAIN GEL

Oxetacaine 10mg + Aluminium Hydroxide 0.291gm

Pack:200ml
Syrup
TRYLAX

TRYLAX

Liquid Paraffin 1.25ml + Milk of Magnesia 3.75ml + Sodium Picosulphate 3.33mg

Pack:170ml
Syrup
SYPROVIT

SYPROVIT

Cyproheptadine HCl 2mg + Tricholine Citrate 0.275mg

Pack:200ml
Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of SAPSNAS-P

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.